President & Immunovant CEO
Tue, Oct 7, 2025
Oct 7
180,859 shares @ $3.85
Increased holdings by +10.80%
100th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
39% win rate · -1.6% median edge vs SPY (69 trades, 90-day)
Insider trade was 76% below market price
Price 40% above 200-day moving average